Disease: Acute myeloid leukemia
- 8-Cl-Ado and 8-NH(2)-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia
- A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
- A 69 long non-coding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML
- A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related
- A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias
- A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome
- Advancements and Challenges in the Treatment of AML
- Advances in decision support for diagnosis and early management of acute leukaemia
- Alternative polyadenylation quantitative trait loci contribute to acute myeloid leukemia risk genes regulation
- AML treatment: conventional chemotherapy and emerging novel agents
- Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies
- Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis
- Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article
- Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
- Batimastat Induces Cytotoxic and Cytostatic Effects in In Vitro Models of Hematological Tumors
- Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-kappaB inhibition and the induction of oxidative stress
- Capnocytophaga sputigena Tonsillitis in a Patient With Acute Myeloid Leukemia
- CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment
- Chemical Modifications to Enhance the Drug Properties of a VIP Receptor Antagonist (ANT) Peptide
- Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
- Clinical Analysis of Mitoxantrone Liposome in the Treatment of Children with High-Risk Acute Myeloid Leukemia
- Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with GATA2 Gene Mutation
- Clinical Characteristics of CD4<sup>-</sup>CD56<sup>+</sup> Blastic Plasmacytoid Dendritic Cell Neoplasm
- Clinical outcomes and treatment patterns in adults with FLT3-ITD(mut+) acute myeloid leukemia undergoing allogeneic hemopoietic cell transplantation in the US and Canada
- Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation
- Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment
- Convergent epigenetic evolution drives relapse in acute myeloid leukemia
- Correlation of miR-155 Expression with Drug Sensitivity of FLT3-ITD(+) Acute Myeloid Leukemia Cell Line and Its Mechanism
- Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia
- Curcumin Combined with Thalidomide Inhibits Proliferation of KG-1 Cells and Its Related Mechanisms
- Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors
- Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong <em>In Vivo</em> Antitumor Activity
- Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro
- Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
- Effect of Shikonin on Autophagy and Apoptosis of Human Promyelocytic Leukemia Cells
- Effects of BMAL2 on Aerobic Glycolysis and Cell Proliferation in Acute Myeloid Leukemia Cells
- Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid Leukemia Cells
- Erythroid predominance in bone marrow biopsies of AML patients after decitabine treatment correlates with mutation profile and complete remission
- Evaluating targeted therapies in older patients with <em>TP53</em>-mutated AML
- Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
- Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative
- Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients
- FLT3 agonists and secondary hematopoietic malignancies: a potential class effect
- FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia
- Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with <em>CEBPA</em> Mutation
- Genetic prediction of causal association between serum bilirubin and hematologic malignancies: a two-sample Mendelian randomized and bioinformatics study
- Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia
- Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?
- High throughput screening aids clinical decision-making in refractory acute myeloid leukaemia
- Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis
- Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning
- Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients
- Interaction of olive oil-based propolis and caffeic acid phenethyl ester with methylprednisolone used in the treatment of human acute myeloid leukemia
- Investigating the safety and feasibility of osteopathic manipulative medicine in hospitalized children and adolescent young adults with cancer
- Isolation of acute myeloid leukemia blasts from blood using a microfluidic device
- Latest Findings on the Role of RUNX1 in Bone Development and Disorders
- Leukemia circulation kinetics revealed through blood exchange method
- Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients
- Middle Meningeal Artery Embolization in Acute Leukemia Patients Presenting With Subdural Hematoma
- Mitochondria inside acute myeloid leukemia cells hydrolyze ATP to resist chemotherapy
- Multi-omics data integration and drug screening of AML cancer using generative adversarial network
- Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
- Narazaciclib, a novel multi-kinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models
- NET-related gene signature for predicting AML prognosis
- Overcoming the challenges encountered in CAR-T therapy: latest updates from the 2023 ASH annual conference
- p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes
- Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review
- PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells
- Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K/SREBP-1/SCD1 axis and triggering of lipid peroxidation
- Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
- Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
- Precision off-the-shelf natural killer cell therapies for oncology with logic-gated gene circuits
- Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid Leukemia Cells
- Prognostic Value of IGF2BP3 Gene Expression Levels in Patients with Acute Myeloid Leukemia
- Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Recent advancements in hematopoietic stem cell transplantation in Taiwan
- Research Progress of Isocitrate Dehydrogenase Mutation-Positive Acute Myeloid Leukemia --Review
- Research Progress on the Prognostic Evaluation of MRD in Acute Myeloid Leukemia --Review
- Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia
- RNF138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in AML
- Self-Stimulated Photodynamic Nanoreactor in Combination with CXCR4 Antagonists for Antileukemia Therapy
- SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
- SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
- Survival and Prognosis of Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes Transformed from Myelodysplastic Syndrome
- Survival for the fittest: guadecitabine in rel/ref AML
- Surviving the Storm: Cardiac Tamponade and Effusive Constrictive Pericarditis Complicated by Pericardial Decompression Syndrome Induced by COVID-19 Infection in the Setting of Newly Diagnosed Acute Myeloid Leukemia (AML)
- T cells take aim in AML: targeting IDH2
- T-Cell Engagers-The Structure and Functional Principle and Application in Hematological Malignancies
- Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer
- The Efficacy and Safety of Venetoclax Combined with Azacitidine in the Treatment of Adult Patients with Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
- The Expression of METTL14 in Patients with Newly Diagnosed Acute Myeloid Leukemia and Its Clinical Significance
- The Regulatory Effect of RNA m<sup>6</sup> A Methylation Modification on <em>KDM4B</em> Gene Expression in t (8;21) AML Cells by MeRIP-qPCR
- The Role of NK Cells in Allogeneic Hematopoietic Stem Cell Micro-Transplantation for Acute Myeloid leukemia
- Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
- Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression
- Triangulation of epidemiological evidence and risk of bias evaluation: A proposed framework and applied example using formaldehyde exposure and risk of myeloid leukemias
- Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity
- Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management
- Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT